Results 181 to 190 of about 625,909 (347)

Colophony in mascara as a cause of eyelid dermatitis. Chemical analyses and patch testing.

, 1991
Ann‐Therése Karlberg, Carola Lidén, E. Ehrin   +2 more
openalex   +2 more sources

Review for "Empirical tests of habitat selection theory reveal that conspecific density and patch quality, but not habitat amount, drive long‐distance immigration in a wild bird"

, 2020

openalex   +1 more source

Next‐generation proteomics improves lung cancer risk prediction

Molecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj, Clara Frick, Ben Schöttker, Bernd Holleczek, Hermann Brenner   +4 more
wiley   +1 more source

Evaluating the Efficacy of Soothing Agents in Mitigating 0.1% Retinol-Induced Skin Irritation: A Patch Test. [PDF]

J Cosmet Dermatol
Ying Y, Fang Y, Chenlan X, Lin S, Jiefang H, Yanan L, Peiwen S.   +6 more
europepmc   +1 more source

Effects of dupilumab treatment on patch test reactions: A retrospective evaluation. [PDF]

Clin Exp Allergy, 2021
de Wijs LEM, van der Waa JD, Nijsten T, Silverberg JI, Kunkeler ACM, Hijnen DJ.   +5 more
europepmc   +1 more source

PRS74 Measurement Of A Possible Patch Testing Outcome Indicator [PDF]

, 2011
Rosella Gallo, Alessio Signori, Élisa Cinotti, Aurora Parodi   +3 more
openalex   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

Molecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak, Karolina Pytlak, Sandra Jaworowska, Bogusz Kulawiak, Piotr Bednarczyk   +4 more
wiley   +1 more source

Patch Test Preparations: Basis and State-of-the-Art Modern Diagnostic Tools for Contact Allergy. [PDF]

J Clin Med
Zimmer J, Neimanis S, Schmidt S, Schubert S, Mahler V.   +4 more
europepmc   +1 more source

Biohazard surveillance of allergic contact dermatitis in genetically-modifiedZoysiagrasses using patch testing

, 2015
Jaechun Lee, Hyeon-Jin Sun, Hyo‐Yeon Lee   +2 more
openalex   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source